To this end, we determine that DNA hypermethylation is associated with low expression of NY-ESO-1 and other CTA in serum-free primary patient-derived gliomasphere lines, immortalized glioma cell lines, and GBM patient tissue samples. This evidence concerns the gene CTAG1A and glioblastoma.